Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?
In our cohort of Ro/SS-A antibody-positive patients, an overall increased risk of malignancy was noticed. Regular screening tests including imaging and laboratory values are justified in Ro/SS-A antibody-positive patients who exhibit the mentioned clinical criteria.
Our findings suggest that the p53 codon 72 polymorphism is unlikely to be associated with endometriosis in Japanese women.